Randomized Phase 3 study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) versus Pomalidomide-Dexamethasone (PD) in relapse or refractory myeloma. An AMN study

Authors
Category Primary study
Registry of TrialsKorean Clinical Trials Database
Year 2018
This article has no abstract
Epistemonikos ID: 3e81414bad9961e3014d3d9add9228a6879217d4
First added on: Apr 11, 2025